<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="generate">
            <roleset id="generate.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#x09;&#x09;//gene, process//&#x0A;" />
                    <role n="1" descr="thing created&#x09;&#x09;&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Human leukocyte antigen (HLA)-G molecules will be generated by an alternative splicing of the primary transcript of the gene and will display specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>In addition, the AR N-terminus generates a functional interaction surface, since its deletion abolishes FHL2 binding.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that degradation did not generate specific fragments or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>In the absence of L-arginine, superoxide (O(2)-) was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Prnd can generate major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>The TBC method generated sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>The TBC method generated sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>The bidentate RNase III Dicer is able to generate the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>These are fumarate reductase (encoded by the frdABCD operon), fumarase B, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a monoclonal antibody against FHL2 is generated by us</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>a DNase I hypersensitive is generated by a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>some unusual chimeric transcripts may be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>this binding generates a higher order protein-DNA complex within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>Abeta peptides are generated from proteolysis of the amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="MEDLINE" no="2">
                    <text>The bidentate RNase III Dicer cleaves microRNA precursors to generate the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that NO reacts anaerobically with the Fe-S cluster of purified FNR generated spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that NO reacts anaerobically with the Fe-S cluster of purified FNR is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that Prnd generated major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarase B is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating fumarate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarate has been generated by fumarase B</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarate will be generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarate will be generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that major transcripts of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that proteolysis of the amyloid precursor proteins (APP) is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating Abeta peptides.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that sequential overlapping fragments is generated by The TBC method.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that sequential overlapping fragments will be generated by The TBC method.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex is generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the 21-23 nt long mature RNAs will be generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generates a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro within the recombinational synapse.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) has generated a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of NO reacts anaerobically with the Fe-S cluster of purified FNR, although again the relatively small fraction involved and the possibility that degradation does not generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of nNOS, although again the relatively small fraction involved and the possibility that degradation does not generate superoxide or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of proteolysis of the amyloid precursor proteins (APP), although again the relatively small fraction involved and the possibility that degradation does not generate Abeta peptides or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of us, although again the relatively small fraction involved and the possibility that a monoclonal antibody against FHL2 have not been generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of us, although again the relatively small fraction involved and the possibility that degradation did not generate a monoclonal antibody against FHL2 or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of us, although again the relatively small fraction involved and the possibility that degradation does not generate a monoclonal antibody against FHL2 or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) was generated by proteolysis of the amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>In the absence of L-arginine, The TBC method generated sequential overlapping fragments (O(2)-).</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>In the absence of L-arginine, The TBC method has been shown to generate sequential overlapping fragments (O(2)-).</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>In the absence of L-arginine, a DNase I hypersensitive (O(2)-) has been generated by a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generated a DNase I hypersensitive (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>In the absence of L-arginine, a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generates a DNase I hypersensitive (O(2)-).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>In the absence of L-arginine, degradation generates specific fragments (O(2)-).</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>In the absence of L-arginine, degradation has been shown to generate specific fragments (O(2)-).</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>In the absence of L-arginine, fumarate (O(2)-) has been generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>In the absence of L-arginine, spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex (O(2)-) was generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>In the absence of L-arginine, the 21-23 nt long mature RNAs (O(2)-) is generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>In the absence of L-arginine, the 21-23 nt long mature RNAs (O(2)-) was generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface within the recombinational synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface within the recombinational synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR generated spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex within the recombinational synapse.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR generates spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR has generated spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR was optimized to generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Prnd generates major transcripts of 1.7 and 2.7 kb ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Prnd generates major transcripts of 1.7 and 2.7 kb within the recombinational synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Prnd, generating major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>The TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>These are a DNase I hypersensitive reductase (encoded by the frdABCD operon), a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1), which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>These are a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro reductase (encoded by the frdABCD operon), EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1), which generates fumarate from malate, and the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>These are specific fragments reductase (encoded by the frdABCD operon), degradation, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>These are specific fragments reductase (encoded by the frdABCD operon), degradation, which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>These are spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex reductase (encoded by the frdABCD operon), NO reacts anaerobically with the Fe-S cluster of purified FNR, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>These are superoxide reductase (encoded by the frdABCD operon), nNOS, which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the frdABCD operon), L723 in H3, which generates fumarate from malate, and the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>To analyse specifically protein expression of FHL2 in human tissues EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generated a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>To analyse specifically protein expression of FHL2 in human tissues L723 in H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>To analyse specifically protein expression of FHL2 in human tissues The bidentate RNase III Dicer may generate the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) will generate a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a DNase I hypersensitive was generated by a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) will generate a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a higher order protein-DNA complex was generated by this binding</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, nNOS generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, specific fragments was generated by degradation</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, the 21-23 nt long mature RNAs was generated by The bidentate RNase III Dicer</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>We believe EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) is found to generate a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro within the recombinational synapse.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>We believe proteolysis of the amyloid precursor proteins (APP) is shown to generate Abeta peptides within the recombinational synapse.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro were generated by EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>a monoclonal antibody against FHL2 are generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>a monoclonal antibody against FHL2 have been generated from we by beta- and gamma-secretases.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>a monoclonal antibody against FHL2 is generated by us within the recombinational synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>a monoclonal antibody against FHL2 was generated by we.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>a monoclonal antibody against FHL2 were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>fumarase B generates fumarate ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>fumarase B generates fumarate ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>fumarase B generates fumarate within the recombinational synapse.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>fumarase B is able to generate fumarate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>fumarase B may generate fumarate ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>fumarate are generated from fumarase B by beta- and gamma-secretases.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>major transcripts of 1.7 and 2.7 kb (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>major transcripts of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>nNOS has generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>proteolysis of the amyloid precursor proteins (APP) has generated Abeta peptides.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>proteolysis of the amyloid precursor proteins (APP) may generate Abeta peptides ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>sequential overlapping fragments are generated by The TBC method.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>specific fragments are generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex was generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>superoxide (from malate, and the DcuB permease for fumarate, malate, and aspartate) are generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>the 21-23 nt long mature RNAs (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>the 21-23 nt long mature RNAs (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>the 21-23 nt long mature RNAs are generated from The bidentate RNase III Dicer by beta- and gamma-secretases.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>the 21-23 nt long mature RNAs can be generated from The bidentate RNase III Dicer by beta- and gamma-secretases.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>the correct three-dimensional interaction surface are generated from L723 in H3 by beta- and gamma-secretases.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3 within the recombinational synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3 within the recombinational synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>this binding can generate a higher order protein-DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>this binding, generating a higher order protein-DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>us can generate a monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>us generated a monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>we is able to generate a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that Human leukocyte antigen (HLA)-G molecules was generated by an alternative splicing of the primary transcript of the gene.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that Human leukocyte antigen (HLA)-G molecules will be generated by an alternative splicing of the primary transcript of the gene.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that Human leukocyte antigen (HLA)-G molecules will be generated by an alternative splicing of the primary transcript of the gene.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that a functional interaction surface is generated by the AR N-terminus.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that an RNA splice of 3863 bases occurring in the 5-untranslated region generated mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that an RNA splice of 3863 bases occurring in the 5-untranslated region is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that an RNA splice of 3863 bases occurs in the 5-untranslated region generated mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that an RNA splice of 3863 bases occurs in the 5-untranslated region is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that mature HeLa cell mRNA has been generated by an RNA splice of 3863 bases occurring in the 5-untranslated region</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that mature HeLa cell mRNA is generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that mature HeLa cell mRNA is generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Human leukocyte antigen (HLA)-G molecules an alternative splicing of the primary transcript of the genere generated from we by beta- and gamma-secretases.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Human leukocyte antigen (HLA)-G molecules is generated by an alternative splicing of the primary transcript of the gene within the recombinational synapse.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Human leukocyte antigen (HLA)-G molecules was generated by an alternative splicing of the primary transcript of the gene within the recombinational synapse.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>In addition, there was an apparent absence of loPrndr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation does not generate major transcripts of 1.7 and 2.7 kb or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>In addition, there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that fumarate are not generated by degradation.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>In addition, there was an apparent absence of lointergenic splicing with Prnpr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation did not generate some unusual chimeric transcripts or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>In addition, there was an apparent absence of lointergenic splicing with Prnpr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that some unusual chimeric transcripts have not been generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>In addition, there was an apparent absence of lointergenic splicing with Prnpr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that some unusual chimeric transcripts have not been generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>In addition, there was an apparent absence of lothe AR N-terminusr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that a functional interaction surface have not been generated by degradation.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>In addition, there was an apparent absence of lothe AR N-terminusr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation does not generate a functional interaction surface or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>In addition, there was an apparent absence of lothe AR N-terminusr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation does not generate a functional interaction surface or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>In addition, there was an apparent absence of lothe AR N-terminusr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation does not generate a functional interaction surface or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of an RNA splice of 3863 bases occurring in the 5-untranslated region, although again the relatively small fraction involved and the possibility that mature HeLa cell mRNA will not be generated by degradation.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of an RNA splice of 3863 bases occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that degradation does not generate mature HeLa cell mRNA or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene, although again the relatively small fraction involved and the possibility that Human leukocyte antigen (HLA)-G molecules are not generated by degradation.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene, although again the relatively small fraction involved and the possibility that Human leukocyte antigen (HLA)-G molecules are not generated by degradation.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene, although again the relatively small fraction involved and the possibility that degradation did not generate Human leukocyte antigen (HLA)-G molecules or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of mutating amino acids EE (437 and 438) to AA, although again the relatively small fraction involved and the possibility that The DNA-binding mutant (Stat5aEE-AA) of Stat5a have not been generated by degradation.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>In the absence of L-arginine, Human leukocyte antigen (HLA)-G molecules (O(2)-) is generated by an alternative splicing of the primary transcript of the gene.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) has been generated by the AR N-terminus.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>In the absence of L-arginine, intergenic splicing with Prnp has been shown to generate some unusual chimeric transcripts (O(2)-).</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>In the absence of L-arginine, mature HeLa cell mRNA (O(2)-) has been generated by an RNA splice of 3863 bases occurs in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>In the absence of L-arginine, some unusual chimeric transcripts (O(2)-) has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a (from malate, and the DcuB permease for fumarate, malate, and aspartate) are generated by mutating amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by mutating amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mutating amino acids EE (437 and 438) to AA within the recombinational synapse.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a were generated by mutating amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a were generated from mutating amino acids EE (437 and 438) to AA by beta- and gamma-secretases.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>These are a functional interaction surface reductase (encoded by the frdABCD operon), the AR N-terminus, which generates fumarate from malate, and the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>These are mature HeLa cell mRNA reductase (encoded by the frdABCD operon), an RNA splice of 3863 bases occurs in the 5-untranslated region, which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>To analyse specifically protein expression of FHL2 in human tissues the AR N-terminus may generate a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, Human leukocyte antigen (HLA)-G molecules is generated by an alternative splicing of the primary transcript of the gene</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, Human leukocyte antigen (HLA)-G molecules was generated by an alternative splicing of the primary transcript of the gene</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, Human leukocyte antigen (HLA)-G molecules was generated by an alternative splicing of the primary transcript of the gene</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, an alternative splicing of the primary transcript of the gene generate Human leukocyte antigen (HLA)-G molecules.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, aspartate-ammonia lyase generate fumarate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, mutating amino acids EE (437 and 438) to AA will generate The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, the AR N-terminus will generate a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>We believe an RNA splice of 3863 bases occurring in the 5-untranslated region is found to generate mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>We believe an RNA splice of 3863 bases occurring in the 5-untranslated region is required to generate mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>We believe an RNA splice of 3863 bases occurs in the 5-untranslated region is required to generate mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>We believe an alternative splicing of the primary transcript of the gene is found to generate Human leukocyte antigen (HLA)-G molecules within the recombinational synapse.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>We believe intergenic splicing with Prnp is shown to generate some unusual chimeric transcripts within the recombinational synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>We believe intergenic splicing with Prnp is shown to generate some unusual chimeric transcripts within the recombinational synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>an RNA splice of 3863 bases occurs in the 5-untranslated region generate mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>an RNA splice of 3863 bases occurs in the 5-untranslated region generate mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>an RNA splice of 3863 bases occurs in the 5-untranslated region generated mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>an RNA splice of 3863 bases occurs in the 5-untranslated region generated mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>an RNA splice of 3863 bases occurs in the 5-untranslated region has generated mature HeLa cell mRNA ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>an RNA splice of 3863 bases occurs in the 5-untranslated region was optimized to generate mature HeLa cell mRNA ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>an alternative splicing of the primary transcript of the gene has generated Human leukocyte antigen (HLA)-G molecules ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>an alternative splicing of the primary transcript of the gene is able to generate Human leukocyte antigen (HLA)-G molecules.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>aspartate-ammonia lyase, generating fumarate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>fumarate (from malate, and the DcuB permease for fumarate, malate, and aspartate) are generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>fumarate were generated from aspartate-ammonia lyase by beta- and gamma-secretases.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>fumarate were generated from aspartate-ammonia lyase by beta- and gamma-secretases.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>intergenic splicing with Prnp can generate some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>intergenic splicing with Prnp has generated some unusual chimeric transcripts ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>mature HeLa cell mRNA an RNA splice of 3863 bases occurring in the 5-untranslated regionre generated from we by beta- and gamma-secretases.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>mature HeLa cell mRNA are generated from an RNA splice of 3863 bases occurs in the 5-untranslated region by beta- and gamma-secretases.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>mature HeLa cell mRNA have been generated from an RNA splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>mature HeLa cell mRNA is generated by an RNA splice of 3863 bases occurring in the 5-untranslated region within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>mutating amino acids EE (437 and 438) to AA may generate The DNA-binding mutant (Stat5aEE-AA) of Stat5a ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>some unusual chimeric transcripts are generated from intergenic splicing with Prnp by beta- and gamma-secretases.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>the AR N-terminus was optimized to generate a functional interaction surface ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
